Ground-breaking data demonstrates tissue repair with Istesso’s novel investigational medicines
Istesso’s new class of developmental drugs, which inhibit mitochondrial complex...
17th July 2025Istesso’s new class of developmental drugs, which inhibit mitochondrial complex...
17th July 2025Istesso, the leading adaptive tissue-repair company, is pleased to announce...
4th June 2025I’ve been thinking about Taylor Swift - not for the usual reasons, but in the context of medical innovation.
10th February 2025CEO Lisa Patel wants to invite patients to the table and put their everyday experiences of living with chronic diseases at the forefront of future drug development.
16th October 2023CEO Lisa Patel wants to invite patients to the table and put their everyday experiences of living with chronic diseases at the forefront of future drug development.
17th August 2023CEO Lisa Patel discusses our approach to tackling chronic disease....
17th August 2023Our CEO Lisa Patel booked an ‘appointment’ with Dr Vinay...
21st June 2023What does it mean for a disease to be ‘easy’, and how do we define when a disease is ‘solved’?
19th May 2023Istesso Limited, the programmed disease resolution company, today announces that...
5th December 2022